Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo
13 Dicembre 2017 - 10:55AM
Oslo, Norway, December 13, 2017 - Photocure ASA
(OSE: PHO) announces today that the company will present at the DNB
Nordic Healthcare Conference on 14th of December 2017 in Oslo,
Norway. Presenter will be Ambaw Bellete, President, Photocure Inc.
and Head, US Cancer Commercial Operations. The slides presented
will be available on Photocure's website (www.photocure.com) in the
investor relations section.
Company contact:
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.no
About Photocure
Photocure, headquartered in Oslo Norway, is a specialty
pharmaceutical company focusing on urology. Based on its unique
proprietary Photocure Technology® platform, Photocure is committed
to developing and commercializing highly selective and minimally
invasive solutions to improve health outcomes for patients
worldwide. The company is listed on the Oslo Stock Exchange (OSE:
PHO). More information about Photocure is available at
www.photocure.com, www.hexvix.com, www.cysview.com.
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Photocure ASA via Globenewswire
Grafico Azioni Invesco Water Resources ... (NASDAQ:PHO)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Invesco Water Resources ... (NASDAQ:PHO)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Invesco Water Resources ETF Trust (NASDAQ): 0 articoli recenti
Più Photocure ASA Articoli Notizie